A Rapid Capsaicin-Activated Current in Rat Trigeminal Ganglion Neurons (Pain/Taste/Nociceptive Fibers/Ph/Capsazepine) L

Total Page:16

File Type:pdf, Size:1020Kb

A Rapid Capsaicin-Activated Current in Rat Trigeminal Ganglion Neurons (Pain/Taste/Nociceptive Fibers/Ph/Capsazepine) L Proc. Natl. Acad. Sci. USA Vol. 91, pp. 738-741, January 1994 Neurobiology A rapid capsaicin-activated current in rat trigeminal ganglion neurons (pain/taste/nociceptive fibers/pH/capsazepine) L. LIu* AND S. A. SIMONt Departments of *Neurobiology and tAnesthesiology, Duke University Medical Center, Durham, NC 27710 Communicated by Irving T. Diamond, October 15, 1993 ABSTRACT A subpopulation of pain fibers are activated Na2HPO4, 5.6 mM D-glucose, and 10 mM Hepes. They were by capsaicin, the ingredient in red peppers that produces a then incubated for 40 min at 37°C in HBSS containing 1 mg burning sensation when eaten or placed on skin. Previous of collagenase per ml (type XI-S), triturated with a flamed studies on dorsal root ganglion neurons indicated thatcapsaicin Pasteur pipette, and finally incubated at 37°C for 6 min with activates sensory nerves via a single slowly activating and 0.1 mg of DNase I per ml (type IV). Then they were inactivating inward current. In rat trigeminal neurons, we retriturated and washed/centrifuged three times in HBSS. identified a second capsaicin-activated inward current. This They were then resuspended in F-14 medium (GIBCO) current can be distinguished from the slow one in that it rapidly containing 10%o fetal calf serum in a Petri dish. The cultures activates and inactivates, requires Ca2+ for activation, and is were maintained in an incubator at 37°C equilibrated with 5% insensitive to the potent capsaicin agonist resiniferatoxin. The CO2. Most patch clamp experiments were done on cells rapid current, like the slower one, is inhibited by ruthenium cultured for 12-24 hr. At the beginning of each experiment, red and capsazepine. The two capsaicin-activated inward cur- the neurons were placed in a chamber containing Krebs- rents share many similarities with the two inward currents Henseleit (KH) buffer on an inverted microscope. The com- activated by lowering the pH to 6.0. These similarities include position of KH is 140 mM NaCl, 5 mM KCl, 2.0 mM CaCl2, kinetics, reversal potentials, responses to Ca2+, and inhibition 1.0mM MgCl2, 10 mM Hepes, and 10mM D-glucose (pH 7.4). by ruthenium red and capsazepine. These results suggest that For the Ca2+-free solutions, the KH buffer contained 1 mM acidic stimuli may be an endogenous activator of capsaicin- CaCl2 and 10 mM EGTA. Under these conditions, the free gated currents and therefore may rationalize why pain is Ca2+ and Mg2+ concentrations were calculated to be 7.4 nM produced when the plasma acidity is increased, as occurs and 0.056 mM, respectively. The chamber had a vol of200 p1 during ischemia and inflammation. and KH flowed at a rate of 6 ml/min. Capsaicin, resinifera- toxin (RTX), and capsazepine were dissolved in KH and a Capsaicin is eaten daily by over a third of the world's small concentration of dimethyl sulfoxide. They were added population (1) and produces its pungent taste sensation when to the main flow stream by injection to ensure that the effects it binds to on a subset of and warm were reversible. Experiments were performed at 21°C. receptors nociceptors Whole-cell configuration patch-clamp recordings were per- thermoreceptors (2-8). Upon prolonged application, it blocks formed with an Axoclamp 1D patch-clamp amplifier (Axon nerve fiber conduction and depletes peptides from nerve Instruments, Burlingame, CA). The output was digitized with terminals, which accounts for its clinical use as an analgesic a Digidata 1200 A/D converter (Axon Instruments). Series and anti-inflammatory agent (9, 10). Capsaicin is thought to resistance was compensated but leak currents were not. produce these effects by activating a single type of cation- Electrode resistances were 2-5 Mfl. The microelectrode selective ion channel present in a subset ofnociceptive fibers solution always contained 140 mM KCI, 1.0 mM CaCl2, 2.0 (3). mM MgCl2, 10 mM EGTA, 10 mM Hepes, and 5 mM K2-ATP In the process of investigating the responses of trigeminal (pH 7.2). All drugs were purchased from Sigma except for ganglion cells to chemical stimuli (11, 12), we found that capsazepine, which was purchased from Cookson Chemical capsaicin also activates a current with characteristics quite (Southampton, U.K.). Rat trigeminal cells had a mean mem- distinct from the one previously described. The two currents brane potential of -52 mV (12). activated by capsaicin exhibit many similarities with the two currents activated by acidic stimuli, suggesting that acid may be an endogenous activator of these capsaicin-activated RESULTS currents. In rat trigeminal neurons held at -60 mV and bathed in modified KH buffer, 0.25 ,uM capsaicin activated two inward MATERIALS AND METHODS currents (Fig. 1). This concentration was chosen because it is near the value of the dissociation constant for capsaicin in a Rat trigeminal cells were cultured and whole-cell currents variety of tissues (8). Approximately half the cells tested were recorded by conventional culturing (13) and patch- (57.3%; n = 131) were activated by 0.25 puM capsaicin, but clamp (14) methods. Cells were cultured as follows. Male and different cells displayed different ratios and magnitudes of female Sprague-Dawley rats (150-250 g) were anesthetized these two currents (see Figs. 1-5). The early current (RI-C) with sodium pentobarbital (50 mg per kg of body weight) and activated rapidly with a mean time to peak (ap) and mean their trigeminal ganglia were excised. Trigeminal ganglion inactivation time constant (X) of 1.7 and 3.0 s, respectively. cells were washed several times in cold (4°C) modified In contrast, the later current (SI-C), which has been de- Hanks' balanced salt solution (HBSS) containing 130 mM scribed (5, 15), activated and inactivated more slowly with its NaCl, 5 mM KCl, 0.3 mM KH2PO4, 4 mM NaHCO3, 0.3 mM Abbreviations: DRG, dorsal root ganglion; RTX, resiniferatoxin; The publication costs of this article were defrayed in part by page charge RR, ruthenium red; RI-C, rapidly inactivating capsaicin current; payment. This article must therefore be hereby marked "advertisement" SI-C, slowly inactivating capsaicin current; RI-H, rapidly inactivat- in accordance with 18 U.S.C. §1734 solely to indicate this fact. ing acid current; SI-H, slowly inactivating acid current. 738 Downloaded by guest on October 6, 2021 Neurobiology: Liu and Simon Proc. Natl. Acad. Sci. USA 91 (1994) 739 A B C +RR, 1 uM Capsaicin, 0.25 ,uM Capsaicin, 0.25 ,uM * I X . I 1UUnnApA + Capsazepine, 10 ,M 100 s 100 pA 100 pA 200 pA 7 1 100 s III FIG. 1. Responses of three rat trigeminal ganglion cells to 0.25 AM capsaicin. Capsaicin elicits two inward currents; the extent 1000 pA depends on the particular cell. (A) A cell containing both a RI-C and 100 s a SI-C current of about the same magnitude. (B) A cell containing predominantly SI-C currents. (C) A cell containing predominantly FIG. 3. Inhibition of capsaicin-activated currents by 1 ,uM RR RI-C currents. Arrows indicate the onset of the application of (upper three traces) and 10 uM capsazepine (lower three traces). capsaicin. Vh = -60 mV. Capsaicin (0.25 ,uM; arrow) added to KH buffer (left traces) induced both RI-C and SI-C currents. RR and capsazepine (middle traces) mean rp and r being 24.5 and 40.0 s, respectively. Of the 75 reversibly inhibit the responses to capsaicin (right traces). An capsaicin (0.25 ,M)-activated fibers, 41 had RI-C and SI-C interesting feature seen only with capsazepine is that after extensive currents, where both currents were about the same magni- washout an additional inward current was present (lower right trace). tude (Fig. !A), 21 exhibited predominantly SI-C currents Vh = -60 mV. (Fig. 1B), and 13 exhibited predominantly RI-C currents (Fig. 1C). genic inflammation and pain. In addition, RTX competes with In dorsal root ganglion cells (DRGs), it was shown that the capsaicin for a binding site(s) on DRG and trigeminal ganglion SI-C current is permeable to Na+, K+, and Ca2+ and has a neurons (20). In trigeminal ganglion neurons, which showed reversal potential near 0 mV (5, 16). In trigeminal ganglion both types of capsaicin-activated currents, 2.5 nM RTX (10 neurons, both the RI-C and the SI-C currents also have cells) and 100 nM RTX (5 cells) did not activate the RI-C reversal potentials that ranged between +10 and 0 mV and current. Rather, RTX activated only an inward current, between -10 and 0 mV, respectively (n = 8) (Fig. 2). This having the same time to peak as the SI-C current, but it suggests that they are also permeable to Na+, K+, and remained activated for much longer (Fig. 4A), which could possibly Ca2+ (see below). reflect the very hydrophobic character of RTX. The RTX- Capsaicin-induced fluxes and currents have been shown to induced current was not reversible, even after prolonged be inhibited noncompetitively by ruthenium red (RR) and washing (up to 30 min) with KH buffer. To further demon- competitively by the capsaicin analogue capsazepine (15, 17, strate that the two capsaicin-induced currents are distinct, a 18). Although RR also inhibits a variety of calcium channel trigeminal ganglion cell that elicited both the RI-C and the currents (19), capsazepine appears to be a specific inhibitor SI-C currents was then washed to remove capsaicin and ofcapsaicin-activated currents (15). In rat trigeminal ganglion exposed to 2.5 nM RTX. After the RTX-induced current neurons, both 1 ,uM RR and 10 ,uM capsazepine reversibly became relatively constant, 0.25 uM capsaicin was added to inhibited both the capsaicin (0.25 ,uM)-activated currents the bathing solution and the RI-C current was again activated (Fig.
Recommended publications
  • Chronic Pelvic Pain M
    Guidelines on Chronic Pelvic Pain M. Fall (chair), A.P. Baranowski, S. Elneil, D. Engeler, J. Hughes, E.J. Messelink, F. Oberpenning, A.C. de C. Williams © European Association of Urology 2008 TABLE OF CONTENTS PAGE 1. INTRODUCTION 5 1.1 The guideline 5 1.1.1 Publication history 5 1.2 Level of evidence and grade recommendations 5 1.3 References 6 1.4 Definition of pain (World Health Organization [WHO]) 6 1.4.1 Innervation of the urogenital system 7 1.4.2 References 8 1.5 Pain evaluation and measurement 8 1.5.1 Pain evaluation 8 1.5.2 Pain measurement 8 1.5.3 References 9 2. CHRONIC PELVIC PAIN 9 2.1 Background 9 2.1.1 Introduction to urogenital pain syndromes 9 2.2 Definitions of chronic pelvic pain and terminology (Table 4) 11 2.3 Classification of chronic pelvic pain syndromes 12 Table 3: EAU classification of chronic urogenital pain syndromes (page 10) Table 4: Definitions of chronic pain terminology (page 11) Table 5: ESSIC classification of types of bladder pain syndrome according to the results of cystoscopy with hydrodistension and of biopsies (page 13) 2.4 References 13 2.5 An algorithm for chronic pelvic pain diagnosis and treatment 13 2.5.1 How to use the algorithm 13 2.6 Prostate pain syndrome (PPS) 15 2.6.1 Introduction 16 2.6.2 Definition 16 2.6.3 Pathogenesis 16 2.6.4 Diagnosis 17 2.6.5 Treatment 17 2.6.5.1 Alpha-blockers 17 2.6.5.2 Antibiotic therapy 17 2.6.5.3 Non-steroidal anti-inflammatory drugs (NSAIDs) 17 2.6.5.4 Corticosteroids 17 2.6.5.5 Opioids 17 2.6.5.6 5-alpha-reductase inhibitors 18 2.6.5.7 Allopurinol 18 2.6.5.8
    [Show full text]
  • A Review of the Effects of Pain and Analgesia on Immune System Function and Inflammation: Relevance for Preclinical Studies
    Comparative Medicine Vol 69, No 6 Copyright 2019 December 2019 by the American Association for Laboratory Animal Science Pages 520–534 Overview A Review of the Effects of Pain and Analgesia on Immune System Function and Inflammation: Relevance for Preclinical Studies George J DeMarco1* and Elizabeth A Nunamaker2 One of the most significant challenges facing investigators, laboratory animal veterinarians, and IACUCs, is how to bal- ance appropriate analgesic use, animal welfare, and analgesic impact on experimental results. This is particularly true for in vivo studies on immune system function and inflammatory disease. Often times the effects of analgesic drugs on a particu- lar immune function or model are incomplete or don’t exist. Further complicating the picture is evidence of the very tight integration and bidirectional functionality between the immune system and branches of the nervous system involved in nociception and pain. These relationships have advanced the concept of understanding pain as a protective neuroimmune function and recognizing pathologic pain as a neuroimmune disease. This review strives to summarize extant literature on the effects of pain and analgesia on immune system function and inflammation in the context of preclinical in vivo studies. The authors hope this work will help to guide selection of analgesics for preclinical studies of inflammatory disease and immune system function. Abbreviations and acronyms: CB,Endocannabinoid receptor; CD,Crohn disease; CFA, Complete Freund adjuvant; CGRP,Calcitonin gene-related
    [Show full text]
  • Purinergic P2 Receptors As Targets for Novel Analgesics
    Pharmacology & Therapeutics 110 (2006) 433 – 454 www.elsevier.com/locate/pharmthera Purinergic P2 receptors as targets for novel analgesics Geoffrey Burnstock * Autonomic Neuroscience Centre, Royal Free and University College Medical School, Rowland Hill Street, London NW3 2PF, UK Abstract Following hints in the early literature about adenosine 5V-triphosphate (ATP) injections producing pain, an ion-channel nucleotide receptor was cloned in 1995, P2X3 subtype, which was shown to be localized predominantly on small nociceptive sensory nerves. Since then, there has been an increasing number of papers exploring the role of P2X3 homomultimer and P2X2/3 heteromultimer receptors on sensory nerves in a wide range of organs, including skin, tongue, tooth pulp, intestine, bladder, and ureter that mediate the initiation of pain. Purinergic mechanosensory transduction has been proposed for visceral pain, where ATP released from epithelial cells lining the bladder, ureter, and intestine during distension acts on P2X3 and P2X2/3, and possibly P2Y, receptors on subepithelial sensory nerve fibers to send messages to the pain centers in the brain as well as initiating local reflexes. P1, P2X, and P2Y receptors also appear to be involved in nociceptive neural pathways in the spinal cord. P2X4 receptors on spinal microglia have been implicated in allodynia. The involvement of purinergic signaling in long-term neuropathic pain and inflammation as well as acute pain is discussed as well as the development of P2 receptor antagonists as novel analgesics. D
    [Show full text]
  • Phytochem Referenzsubstanzen
    High pure reference substances Phytochem Hochreine Standardsubstanzen for research and quality für Forschung und management Referenzsubstanzen Qualitätssicherung Nummer Name Synonym CAS FW Formel Literatur 01.286. ABIETIC ACID Sylvic acid [514-10-3] 302.46 C20H30O2 01.030. L-ABRINE N-a-Methyl-L-tryptophan [526-31-8] 218.26 C12H14N2O2 Merck Index 11,5 01.031. (+)-ABSCISIC ACID [21293-29-8] 264.33 C15H20O4 Merck Index 11,6 01.032. (+/-)-ABSCISIC ACID ABA; Dormin [14375-45-2] 264.33 C15H20O4 Merck Index 11,6 01.002. ABSINTHIN Absinthiin, Absynthin [1362-42-1] 496,64 C30H40O6 Merck Index 12,8 01.033. ACACETIN 5,7-Dihydroxy-4'-methoxyflavone; Linarigenin [480-44-4] 284.28 C16H12O5 Merck Index 11,9 01.287. ACACETIN Apigenin-4´methylester [480-44-4] 284.28 C16H12O5 01.034. ACACETIN-7-NEOHESPERIDOSIDE Fortunellin [20633-93-6] 610.60 C28H32O14 01.035. ACACETIN-7-RUTINOSIDE Linarin [480-36-4] 592.57 C28H32O14 Merck Index 11,5376 01.036. 2-ACETAMIDO-2-DEOXY-1,3,4,6-TETRA-O- a-D-Glucosamine pentaacetate 389.37 C16H23NO10 ACETYL-a-D-GLUCOPYRANOSE 01.037. 2-ACETAMIDO-2-DEOXY-1,3,4,6-TETRA-O- b-D-Glucosamine pentaacetate [7772-79-4] 389.37 C16H23NO10 ACETYL-b-D-GLUCOPYRANOSE> 01.038. 2-ACETAMIDO-2-DEOXY-3,4,6-TRI-O-ACETYL- Acetochloro-a-D-glucosamine [3068-34-6] 365.77 C14H20ClNO8 a-D-GLUCOPYRANOSYLCHLORIDE - 1 - High pure reference substances Phytochem Hochreine Standardsubstanzen for research and quality für Forschung und management Referenzsubstanzen Qualitätssicherung Nummer Name Synonym CAS FW Formel Literatur 01.039.
    [Show full text]
  • Trpa1) Activity by Cdk5
    MODULATION OF TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY A, MEMBER 1 (TRPA1) ACTIVITY BY CDK5 A dissertation submitted to Kent State University in partial fulfillment of the requirements for the degree of Doctor of Philosophy by Michael A. Sulak December 2011 Dissertation written by Michael A. Sulak B.S., Cleveland State University, 2002 Ph.D., Kent State University, 2011 Approved by _________________, Chair, Doctoral Dissertation Committee Dr. Derek S. Damron _________________, Member, Doctoral Dissertation Committee Dr. Robert V. Dorman _________________, Member, Doctoral Dissertation Committee Dr. Ernest J. Freeman _________________, Member, Doctoral Dissertation Committee Dr. Ian N. Bratz _________________, Graduate Faculty Representative Dr. Bansidhar Datta Accepted by _________________, Director, School of Biomedical Sciences Dr. Robert V. Dorman _________________, Dean, College of Arts and Sciences Dr. John R. D. Stalvey ii TABLE OF CONTENTS LIST OF FIGURES ............................................................................................... iv LIST OF TABLES ............................................................................................... vi DEDICATION ...................................................................................................... vii ACKNOWLEDGEMENTS .................................................................................. viii CHAPTER 1: Introduction .................................................................................. 1 Hypothesis and Project Rationale
    [Show full text]
  • Systemic Chemical Desensitization of Peptidergic Sensory Neurons with Resiniferatoxin Inhibits Experimental Periodontitis
    The Open Dentistry Journal, 2011, 5, 1-6 1 Open Access Systemic Chemical Desensitization of Peptidergic Sensory Neurons with Resiniferatoxin Inhibits Experimental Periodontitis Torbjørn Breivik1,2,*, Yngvar Gundersen2, Per Gjermo1, Inge Fristad3 and Per Kristian Opstad2 1Department of Periodontology, Faculty of Dentistry, University of Oslo, Norway 2Norwegian Defence Research Establishment, Division for Protection, Kjeller, Norway 3Department of Clinical Dentistry - Endodontics, University of Bergen, Bergen, Norway Abstract: Background and objective: The immune system is an important player in the pathophysiology of periodontitis. The brain controls immune responses via neural and hormonal pathways, and brain-neuro-endocrine dysregulation may be a central determinant for pathogenesis. Our current knowledge also emphasizes the central role of sensory nerves. In line with this, we wanted to investigate how desensitization of peptidergic sensory neurons influences the progression of ligature- induced periodontitis, and, furthermore, how selected cytokine and stress hormone responses to Gram-negative bacterial lipopolysaccharide (LPS) stimulation are affected. Material and methods: Resiniferatoxin (RTX; 50 μg/kg) or vehicle was injected subcutaneously on days 1, 2, and 3 in stress high responding and periodontitis-susceptible Fischer 344 rats. Periodontitis was induced 2 days thereafter. Progres- sion of the disease was assessed after the ligatures had been in place for 20 days. Two h before decapitation all rats re- ceived LPS (150 μg/kg i.p.) to induce a robust immune and stress response. Results: Desensitization with RTX significantly reduced bone loss as measured by digital X-rays. LPS provoked a signifi- cantly higher increase in serum levels of the pro-inflammatory cytokine tumour necrosis factor (TNF)-, but lower serum levels of the anti-inflammatory cytokine interleukin (IL)-10 and the stress hormone corticosterone.
    [Show full text]
  • Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1
    US 20190192440A1 (19 ) United States (12 ) Patent Application Publication ( 10) Pub . No. : US 2019 /0192440 A1 LI (43 ) Pub . Date : Jun . 27 , 2019 ( 54 ) ORAL DRUG DOSAGE FORM COMPRISING Publication Classification DRUG IN THE FORM OF NANOPARTICLES (51 ) Int . CI. A61K 9 / 20 (2006 .01 ) ( 71 ) Applicant: Triastek , Inc. , Nanjing ( CN ) A61K 9 /00 ( 2006 . 01) A61K 31/ 192 ( 2006 .01 ) (72 ) Inventor : Xiaoling LI , Dublin , CA (US ) A61K 9 / 24 ( 2006 .01 ) ( 52 ) U . S . CI. ( 21 ) Appl. No. : 16 /289 ,499 CPC . .. .. A61K 9 /2031 (2013 . 01 ) ; A61K 9 /0065 ( 22 ) Filed : Feb . 28 , 2019 (2013 .01 ) ; A61K 9 / 209 ( 2013 .01 ) ; A61K 9 /2027 ( 2013 .01 ) ; A61K 31/ 192 ( 2013. 01 ) ; Related U . S . Application Data A61K 9 /2072 ( 2013 .01 ) (63 ) Continuation of application No. 16 /028 ,305 , filed on Jul. 5 , 2018 , now Pat . No . 10 , 258 ,575 , which is a (57 ) ABSTRACT continuation of application No . 15 / 173 ,596 , filed on The present disclosure provides a stable solid pharmaceuti Jun . 3 , 2016 . cal dosage form for oral administration . The dosage form (60 ) Provisional application No . 62 /313 ,092 , filed on Mar. includes a substrate that forms at least one compartment and 24 , 2016 , provisional application No . 62 / 296 , 087 , a drug content loaded into the compartment. The dosage filed on Feb . 17 , 2016 , provisional application No . form is so designed that the active pharmaceutical ingredient 62 / 170, 645 , filed on Jun . 3 , 2015 . of the drug content is released in a controlled manner. Patent Application Publication Jun . 27 , 2019 Sheet 1 of 20 US 2019 /0192440 A1 FIG .
    [Show full text]
  • Ryssenvanmphilthesis2006 Original C.Pdf
    University of St Andrews Full metadata for this thesis is available in St Andrews Research Repository at: http://research-repository.st-andrews.ac.uk/ This thesis is protected by original copyright The Synthesis and Photolysis Studies of Caged TRPV1 Ligands St Andrews School of Chemistry and Centre for Biomolecular Sciences University of St Andrews Fife, Scotland March 2006 Michael Van Ryssen Dissertation submitted to the University of St Andrews in application for the degree of Master of Philosophy Supervisor: Dr Stuart J. Conway Abstract A number of transient receptor potential vanilloid subtype 1 (TRPV1) ligands were synthesised and protected with photolabile protecting groups in order to furnish "caged" compounds 79, 120,121 and 123. no2 79 h3co' h3co och3 121 125 Photolysis of compounds 120 and 125 was studied both in vitro and using 1H NMR analysis. It was demonstrated that photolysis of compound 120 and 125 was occurring to different extents when photolysed with a 375 nm immersion lamp. In subsequent studies it was shown that compound 125 could be photolysed using a 405 nm laser, while compound 120 was unaffected under these conditions. The UVA/is spectra of the remaining caged compounds were studied and indicate that it should be possible to photolyse these compounds in a wavelength dependent manner. l Acknowledgements First of all I am indebted to my supervisor, Dr S. J. Conway, for his endless patience, guidance and support throughout the course of this work. Secondly, I would like to thank all the members of the Conway group and BMS Lab. 3.08 for their experimental assistance and encouragement, with special thanks to Dr G.
    [Show full text]
  • Thesis for Word XP
    From the Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden Roles of the Transient Receptor Potential Channels and the Intracellular Ca2+ Channels in Ca2+ Signaling in the -cells Amanda Jabin Fågelskiöld Stockholm 2011 1 All previously published papers were reproduced with permission from the publishers. Published by Karolinska Institutet. Printed by Universitetsservice US-AB digitaltryck. © Amanda Jabin Fågelskiöld, 2011 ISBN 987-91-7457-216-2 2 If we knew what it was we were doing, it would not be called research, would it? Albert Einstein To my beloved family, 3 Academic dissertation for PhD degree at Karolinska Institutet Public defence at Aulan, 6th floor, Södersjukhuset, Stockholm Friday, March 25th, 2011 at 09.00 Supervisor: Docent Md Shahidul Islam, [email protected], Department of Clinical Sciences and Education, Södersjukhuset, Karolinska Institutet. Co-supervisor: Professor Håkan Westerblad, Department of Physiology and Pharmacology, Karolinska Institutet Opponent: Professor Antony Galione, Department of Pharmacology, Oxford University, England, U.K. Examination board: Docent Carani Sanjeevi, Department of Medicine, Solna, Karolinska Institutet Docent Robert Bränström, Department of Molecular Medicine and Surgery, Karolinska Institutet Docent Anna Forsby, Department of Neurochemistry, Stockholm University 4 1 Abstract Previous studies from our group reported that pancreatic -cells express ryanodine receptors (RyRs) that can mediate Ca2+-induced Ca2+ release (CICR). The full consequences of the activation of RyRs on Ca2+ signaling in these cells, however, remained unclear. An important open question was whether activation of the RyRs leads to activation of any Ca2+ channels in the plasma membrane, and thereby depolarizes membrane potential. One main aim of the thesis was to address this question.
    [Show full text]
  • Antioxidants: Novel Approach to ROS Sensitive TRP Channels Gating Manner
    Electronic Journal of Biology, 2017, Vol.13(3): 243-246 Antioxidants: Novel Approach to ROS Sensitive TRP Channels Gating Manner Ahmi ÖZ1, Ömer Çelik1,2, Bejarano I3, Abdülhadi Cihangir Uğuz1,2,* 1 Department of Biophysics, School of Medicine, Suleyman Demirel University, Isparta, Turkey; 2 Neuroscience Research Center, Suleyman Demirel University, Isparta, Turkey; 3 Department of Physiology, Faculty of Science, University of Extremadura, Badajoz, Spain. *Corresponding author. Tel: +90 246 211 37 21; Fax: +90 246 237 11 65; E-mail: [email protected] Citation: Ahmi ÖZ, Çelik Ö, Bejarano I, et al. Antioxidants: Novel Approach to ROS Sensitive TRP Channels Gating Manner. Electronic J Biol, 13:3 Received: July 19, 2017; Accepted: June 23, 2017; Published: June 30, 2017 Review Article (TRP) channels superfamily consists ofcommonly, Abstract Ca2+ permeable,non-selective cation channels including reactive oxygen species (ROS) sensitive Reactive Oxygen Species (ROS) trigger oxidative melastatin like 2(TRPM2), vanilloid 1 (TRPV1) and stress conditions which leads cellular damage. ankyrin 1 (TRPA1) cation channel subtypes [1]. Oxidative stress is the unbalanced situation in favour The balance between oxidants and antioxidants to the oxidants. Free oxygen radicals, in unstable determinestheredox status in the cells. Antioxidant conditions, may function as signal transduction defense has coupled mechanisms including the cell molecules. Transient Receptor Potential (TRP) membrane and cytosolic components. When the lipid channels, as Ca2+- permeable cation channels, that sense environmental changes, such as pH, peroxidation is quenched by membrane antioxidants, temperature, chemical, etc. TRP channels attract enzymatic antioxidants scavenge the harmful ROS scientist’s interest due to their vital role in cellular products in liquid phase [2,3].
    [Show full text]
  • (RTX) Ameliorates Acute Respiratory Distress Syndrome (ARDS) In
    bioRxiv preprint doi: https://doi.org/10.1101/2020.09.14.296731; this version posted September 14, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Resiniferatoxin (RTX) ameliorates acute respiratory distress syndrome (ARDS) in a rodent model of lung injury Taija M. Hahka1,2*, Zhiqiu Xia1,2*, Juan Hong1,2, Oliver Kitzerow3, Alexis Nahama3, Irving H. Zucker 2, Hanjun Wang1,2 1Department of Anesthesiology, University of Nebraska Medical Center 2Department of Cellular and Integrative Physiology, University of Nebraska Medical Center 3Sorrento Therapeutics, Inc., San Diego, CA Running title: Pulmonary Afferents and Acute Lung Injury Address correspondence to: Han-Jun Wang M.D., Department of Anesthesiology, University of Nebraska Medical Center, Omaha, NE 68198, USA. Tel: 1-402-559-2493, Fax: 1-402-559-4438; E-mail: [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.09.14.296731; this version posted September 14, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Acute lung injury (ALI) is associated with cytokine release, pulmonary edema and in the longer term, fibrosis. A severe cytokine storm and pulmonary pathology can cause respiratory failure due to acute respiratory distress syndrome (ARDS), which is one of the major causes of mortality associated with ALI. In this study, we aimed to determine a novel neural component through cardiopulmonary spinal afferents that mediates lung pathology during ALI/ARDS.
    [Show full text]
  • Aromatase Inhibitors Produce Hypersensitivity In
    AROMATASE INHIBITORS PRODUCE HYPERSENSITIVITY IN EXPERIMENTAL MODELS OF PAIN: STUDIES IN VIVO AND IN ISOLATED SENSORY NEURONS Jason Dennis Robarge Submitted to the faculty of the University Graduate School in partial fulfillment of the requirements for the degree Doctor of Philosophy in the Department of Pharmacology and Toxicology, Indiana University September 2014 Accepted by the Graduate Faculty, of Indiana University, in partial fulfillment of the requirements for the degree of Doctor of Philosophy. ___________________________________ David A. Flockhart, M.D., Ph.D., Chair ___________________________________ Jill C. Fehrenbacher, Ph.D. Doctoral Committee ___________________________________ Rajesh Khanna, Ph.D. ___________________________________ Todd C. Skaar, Ph.D. June 9, 2014 ___________________________________ Michael R. Vasko, Ph.D. ii DEDICATION For Dad iii ACKNOWLEDGEMENTS This scientific endeavor was possible with the support, guidance, and collaboration of many individuals at Indiana University. Foremost, I am grateful for the mentorship of two excellent scientists, Dr. David Flockhart and Dr. Michael Vasko, who encouraged me to pursue scientific questions with thoughtful ambition. For the rest of my scientific career, I will always ask two critical questions: “What’s the clinical impact?” and “What’s the question?”. I am also equally thankful for the friendship and mentorship of many members of the Vasko lab family. I enjoyed so many enlightening conversations about scientific and non-scientific matters alike with Dr. Djane Duarte, Dr. Ramy Habashy, Behzad Shariati, and others. I thank Dr. Todd Skaar, Dr. Rajesh Khanna, and Dr. Jill Fehrenbacher for their encouragement and fair critique as members of my committee. I would especially like to thank my family. To my parents, who provided me with every opportunity to pursue higher education and were unwavering in their support and confidence in me.
    [Show full text]